Medicine and Life Sciences - Pharmacology

A major UK clinical trial co-led by researchers at UCL will test whether lower doses of common hormone therapies can treat advanced prostate cancer while reducing the severe side effects many patients experience.

The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world's largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate.

Meet the UCL Change Builders helping to drive progress for our community of staff, students and partners.

People in the most socioeconomically deprived areas of the UK are more likely to die from head and neck cancer, more likely to be diagnosed at advanced stages, and more likely to wait longer for treatment than those in the most affluent areas, according to new analysis.

Clinician researchers at UCL and UCLH are leading a major UK clinical trial to test whether proton beam therapy (PBT) can significantly improve survival rates for patients with mesothelioma, a rare and aggressive cancer of the lining of the lung.

The recreational drugs cannabis, cocaine and amphetamines significantly increase the risk of stroke - including among younger users - Cambridge researchers have concluded after analysing data from more than 100 million people.